Brief: Lisata Therapeutics Q2 EPS USD -0.5
14/08/2023 23:19
Aug 14 (Reuters) - Lisata Therapeutics Q2 net income USD -4.027 million. * Q2 EPS USD -0.5 * Q2 operating expenses USD 6.875 million * Q2 operating income USD -6.875 million
Recent news on Lisata Therapeutics
See all newsBrief: Lisata Therapeutics - Amends Merger Offer Price To $4 Per Share Plus CVR
Brief: Lisata Therapeutics Enters Into Definitive Agreement To Be Acquired By Kuva Labs, Inc.
U.S. STOCKS ON THE MOVE-Oklo, AMD, Lam Research
U.S. STOCKS ON THE MOVE-Aligos, Intel, Travelers Companies
Lisata jumps as Kuva Labs strikes acquisition deal